CALCIMEDICA(CALC),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

CALC CALCIMEDICA

Trading 02-05 12:32:05 EST

0.5403

-0.1197

-18.14%

High0.6568	Low0.5201	Vol600.46K
Open0.6295	D1 Closing0.6600	Amplitude20.71%
Mkt Cap7.79M	Tradable Cap3.62M	Total Shares14.41M
T/O358.71K	T/O Rate8.97%	Tradable Shares6.70M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"CALC","market":"US","secType":"STK","nameCN":"CALCIMEDICA","latestPrice":0.5403,"timestamp":1770312716571,"preClose":0.66,"halted":0,"volume":600462,"delay":0,"changeRate":-0.1813636363636364,"floatShares":6696300,"shares":14409400,"eps":-1.613603,"marketStatus":"Trading","change":-0.1197,"latestTime":"02-05 12:32:05 EST","open":0.6295,"high":0.6568,"low":0.5201,"amount":358709.393718,"amplitude":0.207121,"askPrice":0.5699,"askSize":100,"bidPrice":0.5284,"bidSize":100,"shortable":0,"etf":0,"ttmEps":-1.613603,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1770325200000},"marketStatusCode":2,"adr":0,"listingDate":1601006400000,"exchange":"NASDAQ","adjPreClose":0.66,"preHourTrading":{"tag":"盘前","latestPrice":0.6298,"preClose":0.66,"latestTime":"09:28 EST","volume":16845,"amount":10700.979967500001,"timestamp":1770301687005,"change":-0.0302,"changeRate":-0.045758,"amplitude":0.064091},"postHourTrading":{"tag":"盘后","latestPrice":0.629546,"preClose":0.66,"latestTime":"19:51 EST","volume":50570,"amount":32284.4096,"timestamp":1770252712401,"change":-0.030454,"changeRate":-0.046142,"amplitude":0.084394},"volumeRatio":0.519209,"impliedVol":1.8027,"impliedVolPercentile":0.2353},"requestUrl":"/m/hq/s/CALC/wiki","defaultTab":"wiki","newsList":[{"id":"2607349270","title":"This CalciMedica Analyst Is No Longer Bullish; Here Are Top 4 Downgrades For Thursday","url":"https://stock-news.laohu8.com/highlight/detail?id=2607349270","media":"Benzinga_recent_news","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607349270?lang=en_us&edition=fundamental","pubTime":"2026-01-30 00:28","pubTimestamp":1769704080,"startTime":"0","endTime":"0","summary":"Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.\nConsidering buying CALC stock? Here’s what analysts think: \nPhoto via Shutterstock","market":"hk","thumbnail":"https://cdn.benzinga.com/files/images/story/2026/01/29/Analyst-Woman-Working-With-Information-D_0.jpeg?optimize=medium&dpr=2&auto=webp&width=240","type":0,"news_type":0,"thumbnails":["https://cdn.benzinga.com/files/images/story/2026/01/29/Analyst-Woman-Working-With-Information-D_0.jpeg?optimize=medium&dpr=2&auto=webp&width=240"],"rights":{"source":"benzinga_recent_news","url":"https://www.benzinga.com/analyst-stock-ratings/downgrades/26/01/50237685/this-calcimedica-analyst-is-no-longer-bullish-here-are-top-4-downgrades-for-thursday","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/analyst-stock-ratings/downgrades/26/01/50237685/this-calcimedica-analyst-is-no-longer-bullish-here-are-top-4-downgrades-for-thursday","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"benzinga_recent_news","symbols":["CALC","BK4112"],"gpt_icon":0},{"id":"2607847600","title":"HC Wainwright Downgrades CalciMedica to Neutral From Buy","url":"https://stock-news.laohu8.com/highlight/detail?id=2607847600","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607847600?lang=en_us&edition=fundamental","pubTime":"2026-01-29 20:26","pubTimestamp":1769689587,"startTime":"0","endTime":"0","summary":"CalciMedica (CALC) has an average rating of overweight and mean price target of $16.25, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["CALC","BK4007"],"gpt_icon":0},{"id":"2607089704","title":"CalciMedica Cut to Neutral From Buy by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2607089704","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607089704?lang=en_us&edition=fundamental","pubTime":"2026-01-29 19:52","pubTimestamp":1769687520,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/CALC/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  January 29, 2026 06:52 ET (11:52 GMT)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CALC","BK4007"],"gpt_icon":0},{"id":"2607865370","title":"CalciMedica downgraded to Neutral from Buy at H.C. Wainwright","url":"https://stock-news.laohu8.com/highlight/detail?id=2607865370","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607865370?lang=en_us&edition=fundamental","pubTime":"2026-01-29 19:11","pubTimestamp":1769685078,"startTime":"0","endTime":"0","summary":"H.C. Wainwright downgraded CalciMedica (CALC) to Neutral from Buy without a price target The immediate discontinuation for the Phase 2 KOURAGE clin...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/calcimedica-downgraded-to-neutral-from-buy-at-h-c-wainwright-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/calcimedica-downgraded-to-neutral-from-buy-at-h-c-wainwright-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","CALC"],"gpt_icon":0},{"id":"2607726109","title":"CalciMedica Inc - Discontinues Phase 2 Kourage Trial - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2607726109","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607726109?lang=en_us&edition=fundamental","pubTime":"2026-01-29 06:30","pubTimestamp":1769639432,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260128:nFWN3YT1EW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CALC","BK4007"],"gpt_icon":0},{"id":"2607272643","title":"CalciMedica: Updates Financial Guidance After Trial Discontinuation, NOW Expects Funds to Last Into Q4 2026 - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2607272643","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607272643?lang=en_us&edition=fundamental","pubTime":"2026-01-29 06:30","pubTimestamp":1769639432,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260128:nFWN3YT1EW:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CALC","BK4007"],"gpt_icon":0},{"id":"2607726157","title":"CalciMedica Extends Cash Runway Into Fourth Quarter of 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2607726157","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607726157?lang=en_us&edition=fundamental","pubTime":"2026-01-29 06:29","pubTimestamp":1769639376,"startTime":"0","endTime":"0","summary":"CalciMedica Inc. has updated its financial guidance following the discontinuation of its Phase 2 KOURAGE clinical trial. The company now anticipates that its existing cash, cash equivalents, and short-term investments will be sufficient to fund its current operating plan into the fourth quarter of 2026. This marks an improvement from its previous expectation, which projected funding only into the second half of 2026, reflecting a reduction in planned operating expenses.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. CalciMedica Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on January ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260128:nNDL2Nxtt1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","CALC"],"gpt_icon":0},{"id":"2607774346","title":"Calcimedica Inc trading resumes","url":"https://stock-news.laohu8.com/highlight/detail?id=2607774346","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607774346?lang=en_us&edition=fundamental","pubTime":"2026-01-28 23:40","pubTimestamp":1769614822,"startTime":"0","endTime":"0","summary":"10:35 EST Calcimedica (CALC) Inc trading resumes Published first on TheFly – the ultimate source for real-time, market-moving breaking financial ne...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/calcimedica-inc-trading-resumes-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/calcimedica-inc-trading-resumes-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CALC","BK4007"],"gpt_icon":0},{"id":"2606748845","title":"CalciMedica Shares Hit 52-Week Low After Ending Auxora Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2606748845","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606748845?lang=en_us&edition=fundamental","pubTime":"2026-01-28 23:09","pubTimestamp":1769612940,"startTime":"0","endTime":"0","summary":"CalciMedica shares were 82% lower, at 91 cents, after the company said it was discontinuing its Phase 2 clinical trial evaluating Auxora in patients with Stage 2 or Stage 3 acute kidney injury with associated acute hypoxemic respiratory failure.The stock hit its 52-week low of 82 cents earlier in the session, and is down 66% in the past 12 months.The clinical-stage biopharmaceutical company said the decision follows a recommendation from the trial's independent data monitoring committee.During a prescheduled interim data review, the committee identified a safety concern that, in its view, warrants reevaluation of the study design, particularly with respect to patient enrollment criteria.The company said that there were no deaths in the trial that were assessed by investigators or CalciMedica as being related to study drug, with either Auxora or a placebo. No serious adverse events met the criteria for expedited reporting to the Food and Drug Administration.Based on the committee's reco","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CALC","BK4007"],"gpt_icon":0},{"id":"2606122327","title":"BUZZ-U.S. STOCKS ON THE MOVE-Archer-Daniels-Midland, Danaher, Brinker International","url":"https://stock-news.laohu8.com/highlight/detail?id=2606122327","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606122327?lang=en_us&edition=fundamental","pubTime":"2026-01-28 22:12","pubTimestamp":1769609521,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-Archer-Daniels-Midland, Danaher, Brinker InternationalEikon search string for individual stock moves: STXBZThe Day Ahead newsletter: https://refini.tv/3LI4BU7The Morning N","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260128:nL6N3YT0MC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EXTR","IE0009355771.USD","BK4535","LU0320765489.SGD","LU2430703178.SGD","LU0985481810.HKD","CDE","GEV","LU0795875169.SGD","IE00B894F039.SGD","ABBV","NXT","ADM","LU0314106906.USD","HL","NEM","T","FFIV","AI","KYIV","GKOS","LU2430703095.HKD","AU","ELV","DHR","OTIS","RGNX","PPG","QRVO","LU0211327993.USD","TXN","LU1291159041.SGD","LU1551013425.SGD","GILD","BMY","EAT","SBUX","STEL","SARO","TXT","BROS","LU1489326972.SGD","VFC","VEON","WIX","MRK","LU0823431563.USD","LU1074936037.SGD","CALC"],"gpt_icon":1},{"id":"2606971120","title":"BUZZ-CalciMedica tumbles as safety concerns halt trial of kidney injury drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2606971120","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606971120?lang=en_us&edition=fundamental","pubTime":"2026-01-28 21:29","pubTimestamp":1769606953,"startTime":"0","endTime":"0","summary":"BUZZ-CalciMedica tumbles as safety concerns halt trial of kidney injury drug** Shares of drug developer CalciMedica CALC.O fall 84% to 84 cents premarket** Co says an independent committee flagged safety concerns in the midstage trial of Auxora for severe kidney injury, which could impact the organ's functioning** Committee asked the co to review how patients were being enrolled** No deaths were linked to the drug and no serious side effects required urgent FDA reporting, per co** Co says it will review the data to decide if Auxora can be tested again; all enrolled patients will complete followup** Auxora had previously been tested in pancreatitis and COVID19 pneumonia without major safety issues, per co** Shares up ~86% in 2025","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260128:nL4N3YT1IY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CALC","BK4007"],"gpt_icon":0},{"id":"2606378716","title":"CalciMedica announces discontinuation of Phase 2 KOURAGE clinical trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2606378716","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606378716?lang=en_us&edition=fundamental","pubTime":"2026-01-28 20:12","pubTimestamp":1769602327,"startTime":"0","endTime":"0","summary":"CalciMedica (CALC) announced the discontinuation of its Phase 2 KOURAGE clinical trial evaluating Auxora in patients with Stage 2 or Stage 3 acute ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/calcimedica-announces-discontinuation-of-phase-2-kourage-clinical-trial-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/calcimedica-announces-discontinuation-of-phase-2-kourage-clinical-trial-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CALC","BK4007"],"gpt_icon":0},{"id":"2606151537","title":"BRIEF-CalciMedica Announces Discontinuation Of Phase 2 Kourage Trial In Aki Following Independent Data Monitoring Committee Recommendation","url":"https://stock-news.laohu8.com/highlight/detail?id=2606151537","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606151537?lang=en_us&edition=fundamental","pubTime":"2026-01-28 20:05","pubTimestamp":1769601915,"startTime":"0","endTime":"0","summary":"BRIEF-CalciMedica Announces Discontinuation Of Phase 2 Kourage Trial In Aki Following Independent Data Monitoring Committee RecommendationJan 28 (Reuters) - CalciMedica Inc CALC.O:CALCIMEDICA ANNOUNCE","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260128:nTUA7SYRTP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CALC","BK4007"],"gpt_icon":0},{"id":"2606771303","title":"CalciMedica Inc: Safety Concern Warrants Reevaluation of Study Design, Including Enrollment Criteria","url":"https://stock-news.laohu8.com/highlight/detail?id=2606771303","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606771303?lang=en_us&edition=fundamental","pubTime":"2026-01-28 20:00","pubTimestamp":1769601602,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260128:nTUA7SYRTP:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CALC","BK4007"],"gpt_icon":0},{"id":"2606510715","title":"CalciMedica Inc: There Were No Deaths in Trial That Were Assessed by Investigators or CalciMedica as Being Related to Study Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2606510715","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606510715?lang=en_us&edition=fundamental","pubTime":"2026-01-28 20:00","pubTimestamp":1769601602,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260128:nTUA7SYRTP:5","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","CALC"],"gpt_icon":0},{"id":"2606171584","title":"CalciMedica Inc: Potential Future Trial With Auxora in Aki to Be Evaluated After Data Analysis","url":"https://stock-news.laohu8.com/highlight/detail?id=2606171584","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606171584?lang=en_us&edition=fundamental","pubTime":"2026-01-28 20:00","pubTimestamp":1769601602,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260128:nTUA7SYRTP:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","CALC"],"gpt_icon":0},{"id":"2606713125","title":"NASDAQ TRADE HALT  HALT NEWS PENDING AT 06:55 AM","url":"https://stock-news.laohu8.com/highlight/detail?id=2606713125","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606713125?lang=en_us&edition=fundamental","pubTime":"2026-01-28 19:55","pubTimestamp":1769601300,"startTime":"0","endTime":"0","summary":"NASDAQ TRADE HALT  HALT NEWS PENDING AT 06:55 AM","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260128:nAQN2LJLVD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CALC","BK4007"],"gpt_icon":0},{"id":"2603682127","title":"One new option listing on January 13th","url":"https://stock-news.laohu8.com/highlight/detail?id=2603682127","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603682127?lang=en_us&edition=fundamental","pubTime":"2026-01-13 21:37","pubTimestamp":1768311444,"startTime":"0","endTime":"0","summary":"New option listings for January 13th include Calcimedica Inc (CALC). Published first on TheFly – the ultimate source for real-time, market-moving b...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/one-new-option-listing-on-january-13th-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/one-new-option-listing-on-january-13th-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CALC","BK4007"],"gpt_icon":0},{"id":"2584291026","title":"Oppenheimer Reaffirms Their Buy Rating on CalciMedica (CALC)","url":"https://stock-news.laohu8.com/highlight/detail?id=2584291026","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584291026?lang=en_us&edition=fundamental","pubTime":"2025-11-17 21:55","pubTimestamp":1763387722,"startTime":"0","endTime":"0","summary":"In a report released on November 14, Leland Gershell from Oppenheimer maintained a Buy rating on CalciMedica, with a price target of $20.00. The co...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/oppenheimer-reaffirms-their-buy-rating-on-calcimedica-calc-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/oppenheimer-reaffirms-their-buy-rating-on-calcimedica-calc-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["OPY","CALC"],"gpt_icon":0},{"id":"2582637560","title":"CalciMedica reports Q3 net loss of $7.8 mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2582637560","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582637560?lang=en_us&edition=fundamental","pubTime":"2025-11-12 20:15","pubTimestamp":1762949753,"startTime":"0","endTime":"0","summary":"CalciMedica reports Q3 net loss of $7.8 mlnOverviewCalciMedica reports Q3 net loss of $7.8 mln vs $5.6 mln year-agoPositive FDA discussions on pivotal trial for acute pancreatitis, design expected 1H ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251112:nL1N3WO0DA:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CALC","BK4007"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.calcimedica.com","stockEarnings":[{"period":"1week","weight":-0.472},{"period":"1month","weight":-0.8902},{"period":"3month","weight":-0.7843},{"period":"6month","weight":-0.7591},{"period":"1year","weight":-0.7422},{"period":"ytd","weight":-0.8998}],"compareEarnings":[{"period":"1week","weight":-0.0133},{"period":"1month","weight":-0.0022},{"period":"3month","weight":0.0237},{"period":"6month","weight":0.0769},{"period":"1year","weight":0.1403},{"period":"ytd","weight":0.0063}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.093409},{"month":2,"riseRate":0,"avgChangeRate":-0.227686},{"month":3,"riseRate":0,"avgChangeRate":-0.267862},{"month":4,"riseRate":0.2,"avgChangeRate":-0.060527},{"month":5,"riseRate":0.4,"avgChangeRate":-0.021756},{"month":6,"riseRate":0.4,"avgChangeRate":0.018521},{"month":7,"riseRate":0.4,"avgChangeRate":0.171537},{"month":8,"riseRate":0.4,"avgChangeRate":-0.074652},{"month":9,"riseRate":0.6,"avgChangeRate":-0.007161},{"month":10,"riseRate":0.4,"avgChangeRate":-0.031218},{"month":11,"riseRate":0.333333,"avgChangeRate":0.111978},{"month":12,"riseRate":0.666667,"avgChangeRate":0.040206}],"exchange":"NASDAQ","name":"CALCIMEDICA","nameEN":"CALCIMEDICA"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"CALCIMEDICA(CALC),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest CALCIMEDICA(CALC) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"CALCIMEDICA,CALC,CALCIMEDICA股票,CALCIMEDICA股票老虎,CALCIMEDICA股票老虎国际,CALCIMEDICA行情,CALCIMEDICA股票行情,CALCIMEDICA股价,CALCIMEDICA股市,CALCIMEDICA股票价格,CALCIMEDICA股票交易,CALCIMEDICA股票购买,CALCIMEDICA股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"CALCIMEDICA(CALC),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest CALCIMEDICA(CALC) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction